Fed. Circ. Upholds Unigene Win Over Fortical Patents
The Federal Circuit on Thursday declined to revive Apotex Inc.'s counterclaims and bid for summary judgment in Unigene Laboratories Inc.'s suit alleging the generic-drug maker infringed two patents for Fortical nasal...To view the full article, register now.
Already a subscriber? Click here to view full article